ArticleResearch square2020

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.

Shaoli Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.